© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
October 04, 2020
Finding balance to detect and treat prostate cancer without overtreatment is important for patients.
October 03, 2020
From the Chairman
PARP inhibitors are not only expanding the field of prostate cancer but they're giving men another option for life after cancer.
October 02, 2020
After a recommendation against routine prostate cancer screening, rates of early disease declined while the incidence of advanced disease rose. The trend highlights the difficult balance between screening and potential overtreatment.
October 01, 2020
Primed to knock out cells vulnerable due to DNA-repair problems, PARP inhibitors are ushering in a targeted-drug era in prostate cancer treatment.
For some patients with metastatic kidney cancer, undergoing surgery after targeted or immune therapy sparks better health outcomes.
September 30, 2020
Patients with advanced or metastatic bladder cancer, after responding to initial treatment with chemotherapy, may preserve their health improvements by starting immunotherapy immediately.
After treatment for bladder or prostate cancer, many survivors confront permanent sexual side effects. The good news is that treatments and psychological support are available.
September 29, 2020
A growing number of treatments are available to men whose prostate cancer has spread and become resistant to hormonal therapy.
A woman shares her late husband’s journey with advanced penile cancer to help others receive a diagnosis early, when the disease is still highly treatable and even curable.
September 28, 2020
After enjoying visits from therapy dogs during treatment for testicular cancer, a student pilot decides to volunteer to transport pets needing rescue, shelter or adoption.
Research News and Updates
Forward Momentum, a coalition launched by a biopharmaceutical company and three partners, focuses on the health disparities faced by Black men with prostate cancer.
My Nemesis the Gold-Capped Vial
Patients with Hematologic Cancers Benefit from a Walking Program
Jakafi-Novel Therapy Combo Improves Symptom Burden in Patients with Myelofibrosis
Doctor’s Experience as a Cancer Caregiver Is Helping Educate Others